Updated Top 20 Option Holders Report

Nov 5, 2026 at 10:49 PM EST · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Nov 5, 2026 at 10:49 PM EST · 2 pages · English

Summary by 6ix AI

This announcement replaces the previously released list and provides details on the holders and their respective option amounts. The company is focused on developing novel therapies for oncology, with its lead program currently in clinical trials.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/updated-top-20-option-holders-report-1

Release

ASX Announcement UPDATED TOP 20 OPTION HOLDERS LIST Melbourne, Australia – 6 November 2026: Percheron Therapeutics Limited (ASX: PER) ('the Company'), an international biotechnology company focused on developing novel therapies for oncology, provides an updated Top 20 Option holders list to...

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics